(Q39411380)

11 September 2017

Adiponectin inhibits oxidative stress in human prostate carcinoma cells (English)

1 reference

11 September 2017

1 reference

J-P Lu

1

1 reference

11 September 2017

Z F Hou

2

1 reference

11 September 2017

W C Duivenvoorden

3

1 reference

11 September 2017

K Whelan

4

1 reference

11 September 2017

A Honig

5

1 reference

11 September 2017

J H Pinthus

6

1 reference

11 September 2017

17 January 2012

1 reference

Prostate Cancer and Prostatic Diseases

11 September 2017

1 reference

11 September 2017

15

1 reference

11 September 2017

1

1 reference

11 September 2017

28-35

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2011.53

11 September 2017

0 references

cites work

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Obesity and prostate cancer: epidemiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Populations at high risk for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Adipose tissue-derived factors: impact on health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Prostate cancer and adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Obesity and prostate cancer: a role for adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Obesity and capsular incision at the time of open retropubic radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Neuroimaging study designs, computational analyses and data provenance using the LONI pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Reactive oxygen species and peroxisomes: struggling for balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

AMPK, the metabolic syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Isolation of a human prostate carcinoma cell line (DU 145)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

A new human prostate carcinoma cell line, 22Rv1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Oxidative stress in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Laparoscopic extraperitoneal radical prostatectomy in complex surgical cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Association of energy and fat intake with prostate carcinoma risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

The effects of aging on the molecular and cellular composition of the prostate microenvironment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.53

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.53

1 reference

11 September 2017

1 reference